China Regional Advisory Council

Chair

Shun Lu

  
Shun Lu, MD, PhD, is a Director of the Oncology Department and Professor at Shanghai Chest Hospital. Dr. Lu serves on the International Affairs Committee of the American Society of Clinical Oncology, and Multidisciplinary Cancer Management Courses Working Group. He is also a member of the State Food and Drug Administration Expert Panel, Commissioner of the Oncology Society Chinese Medical Association, Selected Director of the Chinese Lung Cancer Study Association, and Standing Director & Deputy Secretary of the Chinese Society of Clinical Oncology. Dr. Lu is a member of the International Association for the Study of Lung Cancer, Associate Editor of the Journal of Thoracic Oncology, and serves on the editorial board of The Oncologist.
Members

  • Feng Chen

    Professor, Dean, School of Public Health, Nanjing Medical University

  • Xiaoyuan Chen

    Director, GCP Officer, Beijing Tsinghua Changgung Hospital

  • Zhaohua Chen

    Head of Global Climical Data Services, Pfizer China R&D Center

  • Haidong Chi

    CM0, Lilly China

  • Connie Dai

    Vice President, Strategy Innovation and Decision Science, HLT

  • Jianing Di

    Senior Director, China Compound Team Leader, Janssen China R&D

  • John Gong

    CEO, 3DMed

  • Jing He

    SVP, Head of China R&D Global Oncology R&D, Astrazeneca

  • Lihong Huang

    Department of Biostatistics, Zhongshan Hospital, Fudan University

  • Jinjie Hu

    Co-Chair of FDAAA International Network Committee, Senior Consultant, Biologics Consulting Group

  • Amy Jiang

    Head of Quality Office, Harbour Biomed

  • Michael Jiang

    Head of Scientific Relations and Innovation & Business Development, Sanofi

  • Michael Lee

    Vice President, Head of Biometrics, Harbour BioMed

  • Vera Liang

    Director and Global Safety Risk Lead, Safety Surveillance and Risk Management, Pfizer (China) R&D Co., Ltd.

  • Howe Li

    Chairman and CEO, Deltamed Co. Ltd

  • Jintong Li

    Deputy Director of Drug Clinical Trial and Research Center, China-Japan Hospital

  • Mengjuan Li

    HR Head, Asia Pacific R&D and Innovation, Johnson & Johnson

  • Ning Li

    Chief Physician, Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences

  • Shuting Li

    Deputy Director, GCP Alliance, China

  • Daniel Liu

    Chief Science Officer, Beijing Clinical Service Center

  • Jessica Liu

    Vice President, Head of International Business, Tigermed Consulting Co., Ltd

  • Yi Liu

    Head of Clinical Science and Medical Affairs, dMed Biopharmaceutical Co., Ltd

  • Yuwen Liu

    Founding Partner, Bohe Angel Fund

  • Qi Lu

    Director, Ethics Committee Office, Renji Hospital affiliated with Shanghai Jiaotong University School of Medicine

  • Yuan Meng

    Head of Medical Office R&D, I-Mab Biopharma

  • Xiaoyao Mo

    Senior Drug Safety Consultant, Partner, Beijing Reheguangtong

  • Anita Shen

    Sr. Director, Head of Clinical Data Monitoring and Management (DMM),, Pfizer

  • Gary Wang

    VP, Human Resources, APAC, & Co-Lead Global HR, BeiGene

  • Jin Wang

    Partner, McKinsey & Company

  • Liqun Wang

    Founder & CEO, Neukio Biotherapeutics

  • Xingli Wang

    Senior Global Program Clinical Head, Global Drug Development , Novartis China

  • Zaiqi Wang

    CEO, InxMed

  • Zhouyan Wu

    Assoc. Dir, HR Business Partner, MSD R&D (China) Co., Ltd.

  • Ning Xu

    Executive Vice President, Head of Global Clinical Operations, Zailab, Zai Lab

  • Angela Yan

    Senior Vice President, Regulatory Affairs & Strategy, dMed

  • Dina Yang

    Deputy Director, Head of Communications, China Office, Bill & Melinda Gates Foundation

  • Wendy Yan

    Senior Vice President, Head of Regulatory Affairs, BeiGene (Beijing) Co., Ltd.

  • Wei Zhang

    VP, Regional Head of Biometrics and Data Management, Asia/MENA, Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.

  • Xiaojing Zhan

    Senior Director, Drug Safety, Jiangsu Hengrui Medicine Co, Ltd

  • Liping Zhou

    Sr. Director, QA, MSD R&D (China) Co., Ltd

  • Carol Zhu

    Vice President, Portfolio and Project Management, JW Therapeutics

Explore Regional Advisory Councils